Chest. 2021 Jan; 159(1): 449–450.
Zinc and Coronavirus Disease 2019
Causal or Casual Association?
, MD,a,∗ , MD,b and , MDa
Alkesh Kumar Khurana
aDepartment of Pulmonary Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
Sunaina Tejpal Karna
bDepartment of Anesthesiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
Aqeel Hussain
aDepartment of Pulmonary Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
aDepartment of Pulmonary Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
bDepartment of Anesthesiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
∗CORRESPONDENCE TO: Alkesh Kumar Khurana, MD, Pulmonary Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India, 462020
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
This article has been
cited by other articles in PMC.
To the Editor:
We read with interest the article by Yao et al1 this issue of CHEST whereby they have studied the effect of zinc supplementation in hospitalized patients of coronavirus disease 2019 (COVID-19) infection.1 In reference to the patient assessment parameters and results, one very important aspect needs attention. Although the authors have evaluated in detail the baseline clinical and treatment characteristics, they have no data pertaining to serum zinc levels before or after zinc supplementation. We do understand because this was a retrospective analysis with waiver of consent, but one should be cautious about the interpretation of results in this scenario. Before concluding that zinc supplementation did not lead to a statistically significant decrease in mortality or other outcome parameters, we should have data clarifying which patients were zinc deficient and which were not before receiving zinc supplementation. This could have been done by measuring serum zinc levels. It is well mentioned in literature that patients with certain respiratory illnesses, for example, asthma, have decreased serum zinc levels. Ibraheem et al2 recorded the prevalence of 98.3% for low serum zinc levels in children with acute lower respiratory tract infection than that in control subjects of 64.2%.2 Rerksuppaphol and Rerksuppaphol3 have also shown that zinc supplementation reduces the number of hospital days in children with acute lower respiratory tract infection, and their results were substantiated by measuring pre and post supplementation serum zinc levels. Serum zinc level is also the recommended modality to estimate dietary zinc status in individuals.4 Also, in COVID-19 disease, C-reactive protein has emerged as one of the key inflammatory markers, and serum zinc levels also have been found to be inversely proportional to C-reactive protein levels in some surveys.4 This further highlights the importance of getting serum zinc levels before making any conclusions about zinc therapy in such patients. The work done by the authors is worth appreciation; however, a prospective cohort study with pre and post zinc supplementation zinc levels would probably yield better or probably different answers.
Footnotes
FINANCIAL/NONFINANCIAL DISCLOSURES: None declared.
References
1.
Yao J.S., Paguio J.A., Dee E.C., C The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study. Chest. 2021;159(1):108–111. [PMC free article] [PubMed] [Google Scholar]2.
Ibraheem R.M., Johnson A.B., Abdulkarim A.A., Biliaminu S.A. Serum zinc levels in hospitalized children with acute lower respiratory infections in the north-central region of Nigeria. Afr Health Sci. 2014;14:136–142. [PMC free article] [PubMed] [Google Scholar]3.
Rerksuppaphol S., Rerksuppaphol L. A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children. Pediatr Rep. 2019;11(2):7954. [PMC free article] [PubMed] [Google Scholar]4.
McDonald C.M., Suchdev P.S., Krebs N.F. Adjusting plasma or serum zinc concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr. 2020;111(4):927–937. [PMC free article] [PubMed] [Google Scholar]
Facebook
Twitter
Google+